Navigation Links
Novavax Reports First Quarter 2009 Financial Results
Date:5/8/2009

remaining outstanding convertible notes with common stock upon maturity, the Company believes it has sufficient funds to execute its current business plans for at least the next twelve months.

Conference Call

Novavax's management will host its quarterly conference call at 10:00 a.m. eastern time today. The live conference call will be accessible via Novavax's website at www.novavax.com under Investor/Events or by telephone at 1 (866) 225 4091 (U.S. or Canada) or 1-703-639-1128 (International). An archive of the conference call will be available on Novavax's website approximately one hour after the event for 90 days. A replay of the webcast will be available on the website for 90 days after the call and a replay of the conference call will also be available by telephone beginning May 8, 2009 at 1:00 pm through May 13, 2009 at 11:59 pm. To access the replay, dial 1 (888) 266 2081 and enter passcode 1357908.

About Novavax

Novavax, Inc. is a clinical-stage biotechnology company creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like-particle (VLP) technology. The company produces these VLP-based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at www.novavax.com and in the company's various filings with the Securities and Exchange Commission. Additional information about Novavax is available at www.novavax.com and in the company's various filings with the Securities and Exchange Commission.

Forward Looking Statements

Statements herein relating to future financial or business performance, conditions or strategies and other financial and business matters, including
'/>"/>

SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate
2. Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call
3. Novavax Announces Early Retirement of $17 Million of Convertible Debt
4. NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains
5. Novavax Announces New Capital Infusion Through a Strategic Alliance with Cadila Pharmaceuticals of India
6. Novavax Announces New Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call
7. Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call
8. Novavax to Present at Cowen and Company 29th Annual Healthcare Conference
9. NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate Directed Against the Fusion (F) Protein
10. Novavax and Vivalis Sign a Research License Agreement to Use the EB66(R) Cell Line for the Production of Virus Like Particle Based Vaccines
11. Novavax Announces Operational Status of Its Vaccine Pilot Plant and Commercial Launch Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Bruno, CA. (PRWEB) March 04, 2015 ... (CRO) headquartered in the San Francisco Bay Area, will ... Trials (OCT) Israel Conference 2015 on March 25th ... Clinical seeks to build relationships with Israeli life science ... (FDA) clinical trials. The company’s services span all phases ...
(Date:3/4/2015)... Follow us on LinkedIn ... fastest growing technologies in the life sciences industry. Growing ... driving growth in nucleic acid detection technologies like qPCR ... expressions will continue to benefit the qPCR and dPCR ... from pharma, biotech, food & beverage to animal feed, ...
(Date:3/3/2015)... , March 3, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... Global Healthcare Conference in Miami, FL ... David A. Ramsay , Chief Financial Officer, will provide ... through the "Investors" section of Halozyme,s corporate website at ... 90 days following the event. To access the live webcast, ...
(Date:3/3/2015)... March 3, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, ... in Miami.   The live presentation takes ... PT).  The presentation will be webcast and may be ... Listeners are encouraged to visit the ...
Breaking Biology Technology:PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2
... downward trend three years ago many companies cut their ... as the price of computers dropped, allowing businesses to ... services grew. Many IT staffers are wary of returning ... and looked to begin working as an outside IT ...
... who switch from traditional paper phone bills to SBC ... , ,Through the "Save a StampHelp Save a Life" campaign, ... SBC Services Inc. will contribute $1 dollar for every SBC ... to Nov. 15, 2004. , ,In 2004, an estimated 216,000 ...
... of multimedia resources on children's books including audio of ... launched on a Wisconsin Department of Public Instruction ... TeachingBooks is a new service of BadgerLink , ... and other resources to Wisconsin schools, libraries and homes. , ...
Cached Biology Technology:Expetec expands IT staff services in Wisconsin 2Expetec expands IT staff services in Wisconsin 3TeachingBooks brings free K-12 resources to Wisconsin residents 2
(Date:3/4/2015)... 04, 2015 Research and Markets ... the "Global Biometrics Market Forecast and Opportunities, ... The market for biometric authentication systems is projected ... till 2020 The driving forces for ... needs, government projects and constant development in technology. ...
(Date:3/3/2015)... March 3, 2015 Cryoport, Inc. ... advanced cryogenic logistics solutions for the life ... cells, cell lines, clinical research organizations, vaccine ... announced the expansion of its relationship with ... ("Fred Hutch") Clinical Research Division with the ...
(Date:3/2/2015)... , March 2, 2015 Synaptics Inc. ... of human interface solutions, today announced a new ... designed to enable rapid and secure transactions and ... for gaming is a turnkey solution providing mouse ... to quickly integrate fingerprint ID solutions into their ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3
... WI, March 6, 2009 -- As the severity of ... to study the ways that greenhouse gases are released ... emissions is essential to reducing this greenhouse effect, and ... policies in the future. A new book published by ...
... (March 9, 2009)Osteoplastya highly effective minimally invasive ... metastatic bone disease by injecting bone cement ... pain relief, often presenting individuals who are ... effect," according to researchers at the Society ...
... the Canadian Cancer Society have discovered eight similar genes ... the most common of childhood brain cancers. The ... the journal Nature Genetics . "This ... better, more targeted treatments so that more of these ...
Cached Biology News:Understanding soil carbon sequestration: New book presents key concepts 2Metastatic bone disease patients can walk in Lazarus' footsteps 2Metastatic bone disease patients can walk in Lazarus' footsteps 3Researchers discover gene mutations that cause childhood brain cancer 2
Anti-Mouse C-10, Biotin (Polyclonal) (rabbit IgG)...
... to Taura Syndrome Virus Coat ... all tested applications). ... VTNSEGSTIL MNDIPITNQN VVLSKNVTDN LFEVQDQALI ESLSRDVLLH ... N terminal amino acids 25/100 ...
Anti-rat Dipeptidyl Peptidase IV (DPP IV), CD26, Clone 5E8, Monoclonal Antibody...
Purified Mouse anti-Hu Actopaxin (pS8) Storage Temperature: Refrigerate(2 to 8C)...
Biology Products: